CalypsoAI Platform Case Study
Think you can outsmart AI? Announcing ‘Behind The Mask’ – Our all-new cybercrime role-playing game | Play Now
Pharmaceutical
LLM Security and Efficiency for the Pharmaceutical Industry
CalypsoAI is the #1 platform for securing prompts entered into large language models (LLMs), avoiding costly data breaches, increasing operational efficiency, and protecting your organization’s intellectual property (IP) from initial research and drug development to clinical trials and regulatory approval.
The top three business cases our Technology Sector customers use Generative AI to address are:
- Drug Discovery and Development: Generative AI assists in identifying novel drug candidates by generating molecular structures with desired properties, accelerating the discovery process, and potentially leading to the development of new therapies.
- Molecular Design and Optimization: AI algorithms optimize molecular structures to enhance drug efficacy, minimize side effects, and improve pharmacokinetic properties, aiding in the design of safer, more effective medications.
- Personalized Medicine and Patient Stratification: Generative AI enables the analysis of large-scale patient data to identify biomarkers, predict treatment responses, and tailor therapies to individual patients, advancing the field of personalized medicine and improving patient outcomes.
Key CalypsoAI LLM Enablement and Security Feature Suites used:
- Security and Compliance: Ensures data protection and aids regulatory adherence, safeguarding sensitive pharmaceutical information and upholding industry standards.
- Observability & Visibility: Offers transparency and insight into LLM usage, optimizes workflows, and enhances decision-making.
- Testing and Deployment Optimization: Streamlines the development process of LLMs, ensuring efficient deployment and rapid iteration to accelerate drug discovery and development.
- API Integration: Facilitates seamless integration into existing pharmaceutical systems, enhancing data protection and regulatory compliance across the industry.
- Multi-model and multimodal support: Asynchronously enhances research capabilities, fosters innovation, and accelerates drug discovery processes.
- Cost Management and Optimization: Guarantees efficient resource allocation, maximizing budget utilization, and enabling more meaningful research and development initiatives.
The Problem
An employee using an LLM to conduct preliminary research on novel pathways for testing a drug that is still in development includes a partial list of the drug’s active ingredients in the prompts. Even though doing so is strictly against company policy, there is no systematic safeguard in place to block the prompt from leaving the company’s system.
The Challenge
The company’s confidential and experimental IP included in the prompt by the sender has been shared with an unauthorized third party and now resides on that entity’s system. The security of the third party’s system is unknown, potentially exposing the information to additional risk of dissemination if that system is breached. The information could also be included in the LLM’s knowledge base and, therefore, be accessible to all users, putting the organization’s competitive advantage at risk and potentially leading to financial loss and diminished shareholder value.
The Solution
CalypsoAI scanners are customizable to filter for personally identifiable information (PII ); time-limited content, such as product names, scientific terms; legal content; source code; and other types of terminology and IP. Prompts are blocked before the information leaves your organization and the user is alerted that their prompt must be revised prior to being sent. All details of the interaction, including the prompt content, sender, LLM, date, time, and individual scanner results are recorded, providing full auditability and attribution. In addition to protecting your IP, CalypsoAI safeguards your organization’s operations.
We Support
